Treating T3 Deficiency Why T4 Thyroxine Therapy does not Improve Symptoms and Why TSH Suppression does NOT Result in Harm
Why T4 Thyroxine Therapy does not Improve Symptoms and Why TSH Suppression does NOT Result in Harm by Neal Rouzier, MD On Day 1 of the Part I BHRT Workshop
The previous course on thyroid optimization was intended to contrast and explain how and why the endocrine societies and the ATA frighten us into not using thyroid hormone. I introduced the concepts that the endocrinologists use when treating hypothyroid patients as well as their reluctance to prescribe thyroid hormone to SC hypothyroid patients. Despite the plethora of data and studies proving that patients DON’T improve on T4-alone therapy, the ATA and AACE reject all the studies demonstrating that patients DO benefit when T3 is added to T4, but also when DTE is used preferentially in place of T4-alone or T4 and low dose T3. When used correctly, most recent literature overwhelming proves that patients prefer DTE over any other thyroid preparation.
Recent Literature Supports That Low Free T3 was the Highest Independent Predictor of Death in CV Patients
Recent Literature Supports That Low Free T3 was the Highest Independent Predictor of Death in CV Patients Written by Neal Rouzier, MD Recommended Pre-Reading: More Proof and Reasoning that T4
More Proof and Reasoning that T4 Monotherapy Results in Inadequate Conversion Written by Neal Rouzier, MD Recommended Pre-Reading: If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee
I do not believe that there is any one subject in medicine that is as misunderstood, politicized, debated, denigrated, and contentious as thyroid hormone. The pharmaceutical thyroid industry has spent millions on brain-washing physicians and convincing them that thyroxine is the best and only thyroid medicine that should be utilized. So many patients have relayed to me that their PMD will no longer treat them if they continue to take Armour Thyroid.